TrialVaccine2020

A phase I trial evaluating the safety and immunogenicity of a candidate tuberculosis vaccination regimen, ChAdOx1 85A prime - MVA85A boost in healthy UK adults.

Morven Wilkie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.